Form 4: Enliven Therapeutics CFO Benjamin Hohl Executes Option Exercise and Stock Sale Under 10b5-1 Plan
SEC Form 4 Filing
Benjamin Hohl, CFO of Enliven Therapeutics, exercised stock options and sold shares according to a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 3, 2024, Benjamin Hohl, the CFO of Enliven Therapeutics, exercised options to purchase 1,000 shares of common stock at a price of $2.48 per share.
- Simultaneously, Hohl sold 1,000 shares of common stock at a price of $22.50 per share.
- These transactions were executed under a pre-existing Rule 10b5-1 trading plan adopted on June 26, 2023.
- Following the reported transactions, Hohl directly owns 221,120 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company executives. The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by a company executive, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| June 26, 2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| August 2, 2022 | Date of initial vesting of the option for one-fourth of the shares |
| May 3, 2024 | Date of the stock option exercise and sale of shares |
| May 7, 2024 | Date of the signature on the Form 4 filing |
| August 2, 2031 | Expiration date of the stock option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.